Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T16:43:09.365Z.
Calculation as of: 2026-10-06T16:43:09.365Z.
Quote observation: 2026-10-06T16:40:23.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2a84589f7b73c5fc7448e1a11526b61c4e763dd9c6e5f877a8586f943b51ec8b
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Inovio Pharmaceuticals, Inc.
Market Cap
$79.11M
EV/EBIT Ratio
N/A
| NAME | MARKET CAP | EV/EBIT RATIO |
|---|---|---|
| Inovio Pharmaceuticals, Inc. (INO) | $79.11M | N/A |
| Sera Prognostics, Inc. (SERA)vs › | $80.96M | N/A |
| Pulmonx Corporation (LUNG)vs › | $78.35M | N/A |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $78.05M | N/A |
| Nutriband Inc. (NTRB)vs › | $82.36M | N/A |
| MediciNova, Inc. (MNOV)vs › | $82.69M | N/A |
| SkinHealth Systems Inc. (SKIN)vs › | $76.14M | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $82.82M | N/A |
| Outset Medical, Inc. (OM)vs › | $76.47M | N/A |
| LENSAR Inc (LNSR)vs › | $82.59M | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
